Flow-cytometry using the anti-alpha 5 beta 1 Integrin M200 (Volociximab) (TA385969) PBMCs (A) and U93 cells (B) were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of M200 (Volociximab) (TA385969, blue line) at a concentration of 10 microg/ml for 30 mins at RT. After washing, bound antibody was detected using anti-rabbit IgG JK (FITC-conjugate) antibody at 2 microg/ml and cells analyzed on a FACSCanto flow-cytometer.
Flow-cytometry using the anti-alpha 5 beta 1 Integrin M200 (Volociximab) (TA385969) PBMCs (A) and U93 cells (B) were stained with unimmunized rabbit IgG antibody (black line) or the rabbit-chimeric version of M200 (Volociximab) (TA385969, blue line) at a concentration of 10 microg/ml for 30 mins at RT. After washing, bound antibody was detected using anti-rabbit IgG JK (FITC-conjugate) antibody at 2 microg/ml and cells analyzed on a FACSCanto flow-cytometer.
Integrin alpha 5 (ITGA5) Rabbit Monoclonal Antibody [Clone ID: M200 (Volociximab)]
TA385969
ApplicationsFlow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetITGA5
Overview
- SupplierOriGene
- Product NameIntegrin alpha 5 (ITGA5) Rabbit Monoclonal Antibody [Clone ID: M200 (Volociximab)]
- Delivery Days Customer14
- ApplicationsFlow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDM200 (Volociximab)
- Gene ID3678
- Target nameITGA5
- Target descriptionintegrin subunit alpha 5
- Target synonymsCD49 antigen-like family member E; CD49e; fibronectin receptor subunit alpha; fibronectin receptor, alpha polypeptide; fibronectin receptor, alpha subunit; FNRA; integrin alpha-5; integrin alpha-F; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); ITGA5/SLC9B1 fusion; very late activation protein 5, alpha subunit; VLA-5; VLA5A
- HostRabbit
- IsotypeIgG
- Scientific DescriptionRecombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
- ReactivityHuman
- UNSPSC12352203